Rxsight Historical Income Statement

RXST Stock

USD 46.88 0.48 1.03%

Historical analysis of Rxsight income statement accounts such as Interest Expense of 2.7 M, Selling General Administrative of 43.3 M, Total Revenue of 93.5 M or Gross Profit of 56.5 M can show how well Rxsight performed in making a profits. Evaluating Rxsight income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Rxsight's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Rxsight latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rxsight is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

About Rxsight Income Statement Analysis

Rxsight Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Rxsight shareholders. The income statement also shows Rxsight investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Rxsight Income Statement Chart

At this time, Rxsight's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 6.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 43.3 M in 2024.

Tax Provision Net Interest Income Selling General Administrative Total Revenue

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Total Revenue

Total revenue comprises all receipts Rxsight generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most accounts from Rxsight's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Rxsight current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.At this time, Rxsight's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 6.9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 43.3 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	4.0M	4.0M	4.2M	4.4M
Interest Income	54K	1.5M	6.6M	6.9M

Depreciation And Amortization Interest Income

Rxsight income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Non Operating Income Net Other
Tax Provision		0.28	-0.18	-0.13	-0.53	-0.44	-0.27	-0.26	-0.42	0.86	0.3	0.92	-0.34	0.92	-0.29	-0.49	-0.13	0.3	0.24	0.3	1.0	0.36
Net Interest Income	0.28		0.62	0.15	-0.63	-0.25	-0.02	0.1	-0.24	0.48	0.54	-0.04	0.74	-0.04	-0.36	-0.16	0.15	0.54	0.52	0.54	0.28	0.11
Interest Income	-0.18	0.62		0.81	0.22	0.55	0.75	0.83	0.57	-0.2	-0.28	-0.29	0.45	-0.28	0.46	0.62	0.81	-0.28	-0.29	-0.28	-0.18	-0.67
Depreciation And Amortization	-0.13	0.15	0.81		0.58	0.7	0.95	0.96	0.72	-0.33	-0.72	-0.03	-0.11	-0.02	0.73	0.7	1.0	-0.72	-0.73	-0.72	-0.13	-0.78
Interest Expense	-0.53	-0.63	0.22	0.58		0.88	0.77	0.69	0.88	-0.8	-0.95	-0.25	-0.46	-0.24	0.91	0.84	0.58	-0.95	-0.93	-0.95	-0.53	-0.8
Selling General Administrative	-0.44	-0.25	0.55	0.7	0.88		0.89	0.86	1.0	-0.68	-0.86	-0.27	-0.2	-0.27	0.97	0.99	0.7	-0.86	-0.84	-0.86	-0.44	-0.95
Total Revenue	-0.27	-0.02	0.75	0.95	0.77	0.89		0.99	0.91	-0.52	-0.84	-0.13	-0.17	-0.13	0.9	0.89	0.95	-0.84	-0.85	-0.84	-0.27	-0.92
Gross Profit	-0.26	0.1	0.83	0.96	0.69	0.86	0.99		0.88	-0.47	-0.77	-0.16	-0.06	-0.15	0.85	0.87	0.96	-0.77	-0.77	-0.77	-0.26	-0.91
Other Operating Expenses	-0.42	-0.24	0.57	0.72	0.88	1.0	0.91	0.88		-0.66	-0.86	-0.26	-0.2	-0.25	0.97	0.99	0.72	-0.86	-0.85	-0.86	-0.42	-0.95
Operating Income	0.86	0.48	-0.2	-0.33	-0.8	-0.68	-0.52	-0.47	-0.66		0.6	0.74	-0.03	0.74	-0.58	-0.69	-0.33	0.6	0.55	0.6	0.86	0.67
Net Income From Continuing Ops	0.3	0.54	-0.28	-0.72	-0.95	-0.86	-0.84	-0.77	-0.86	0.6		-0.01	0.59	-0.01	-0.94	-0.8	-0.72	1.0	1.0	1.0	0.3	0.79
Ebit	0.92	-0.04	-0.29	-0.03	-0.25	-0.27	-0.13	-0.16	-0.26	0.74	-0.01		-0.66	1.0	-0.06	-0.36	-0.03	-0.01	-0.06	-0.01	0.92	0.28
Research Development	-0.34	0.74	0.45	-0.11	-0.46	-0.2	-0.17	-0.06	-0.2	-0.03	0.59	-0.66		-0.66	-0.41	-0.07	-0.11	0.59	0.62	0.59	-0.34	0.1
Ebitda	0.92	-0.04	-0.28	-0.02	-0.24	-0.27	-0.13	-0.15	-0.25	0.74	-0.01	1.0	-0.66		-0.06	-0.35	-0.02	-0.01	-0.07	-0.01	0.92	0.27
Cost Of Revenue	-0.29	-0.36	0.46	0.73	0.91	0.97	0.9	0.85	0.97	-0.58	-0.94	-0.06	-0.41	-0.06		0.93	0.73	-0.94	-0.94	-0.94	-0.29	-0.91
Total Operating Expenses	-0.49	-0.16	0.62	0.7	0.84	0.99	0.89	0.87	0.99	-0.69	-0.8	-0.36	-0.07	-0.35	0.93		0.7	-0.8	-0.78	-0.8	-0.49	-0.96
Reconciled Depreciation	-0.13	0.15	0.81	1.0	0.58	0.7	0.95	0.96	0.72	-0.33	-0.72	-0.03	-0.11	-0.02	0.73	0.7		-0.72	-0.73	-0.72	-0.13	-0.78
Income Before Tax	0.3	0.54	-0.28	-0.72	-0.95	-0.86	-0.84	-0.77	-0.86	0.6	1.0	-0.01	0.59	-0.01	-0.94	-0.8	-0.72		1.0	1.0	0.3	0.79
Total Other Income Expense Net	0.24	0.52	-0.29	-0.73	-0.93	-0.84	-0.85	-0.77	-0.85	0.55	1.0	-0.06	0.62	-0.07	-0.94	-0.78	-0.73	1.0		1.0	0.24	0.78
Net Income	0.3	0.54	-0.28	-0.72	-0.95	-0.86	-0.84	-0.77	-0.86	0.6	1.0	-0.01	0.59	-0.01	-0.94	-0.8	-0.72	1.0	1.0		0.3	0.79
Income Tax Expense	1.0	0.28	-0.18	-0.13	-0.53	-0.44	-0.27	-0.26	-0.42	0.86	0.3	0.92	-0.34	0.92	-0.29	-0.49	-0.13	0.3	0.24	0.3		0.36
Non Operating Income Net Other	0.36	0.11	-0.67	-0.78	-0.8	-0.95	-0.92	-0.91	-0.95	0.67	0.79	0.28	0.1	0.27	-0.91	-0.96	-0.78	0.79	0.78	0.79	0.36

Click cells to compare fundamentals

Rxsight Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rxsight Historical Income Statement

About Rxsight Income Statement Analysis

Rxsight Income Statement Chart

Tax Provision

Net Interest Income

Total Revenue

Rxsight income statement Correlations

Rxsight Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Rxsight Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Tax Expense	+ 1.0	Tax Provision
Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Selling General Administrative
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Total Other Income Expense Net	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Net Income From Continuing Ops

Non Operating Income Net Other	- 0.96	Total Operating Expenses
Non Operating Income Net Other	- 0.95	Other Operating Expenses
Non Operating Income Net Other	- 0.95	Selling General Administrative
Net Income	- 0.95	Interest Expense
Income Before Tax	- 0.95	Interest Expense
Net Income From Continuing Ops	- 0.95	Interest Expense